News & events

This piece questioning how we see and understand dementia friendly communities, their role and how they may evolve was contributed to the World Alzheimer Report 2019 by Glenn Rees, Chair of ADI, and Dr Linda Barclay, a Senior Lecturer in Philosophy at Monash University who specialises in disability and justice.

In 2016 Spominčica – Alzheimer Slovenija started developing the Dementia Friendly Spots (DFS) programme. It is a national education and awareness-raising programme connecting a wide spectrum of organisations in a network of sites providing information about dementia locally. The network of DFS include: police and fire stations, shops, libraries,…

hinese Pharmaceutical Company Green Valley announces their drug Oligomannate (GV-971) has been granted conditional approval for the treatment of "mild to moderate Alzheimer's disease".

Biogen and Eisai have announced they will file for market approval for an investigational treatment for early Alzheimer’s disease.

Ahead of the G20 Health Ministers Meeting in Okayama, ADI’s Chief Executive Paola Barbarino and Noriyo Washizu of Alzheimer's Association Japan (AAJ) continue to work on progress made earlier in the year at the Osaka Summit.

Ahead of the G20 Health Ministers Meeting in Okayama, ADI Chief Executive Paola was interviewed by one of Japan's largest newspaper.

The Spanish Ministry of Health, Consumption and Social Welfare has announced that they have adopted a national dementia plan.

New Zealand's Dementia Declaration is the result of people affected by dementia getting together and identifying what they need to live well.